Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DOW INC. Capital/Financing Update 2019

May 20, 2019

30381_rns_2019-05-20_bc54d13e-b7cd-453c-aefd-ba67cac98493.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

8-K 1 ss137318_8k.htm CURRENT REPORT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

May 20, 2019

| Commission File Number | Exact Name of Registrant as Specified
in its Charter, Principal Office Address and Telephone
Number | State of Incorporation or Organization | I.R.S. Employer Identification No. |
| --- | --- | --- | --- |
| 001-38646 | Dow Inc. | Delaware | 30-1128146 |
| | 2211 H.H. Dow Way, Midland, MI 48674 | | |
| | (989) 636-1000 | | |
| 001-03433 | The Dow Chemical Company | Delaware | 38-1285128 |
| | 2211 H.H. Dow Way, Midland, MI 48674 | | |
| | (989) 636-1000 | | |

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Registrant Title of each class Trading Symbol(s) Name of each exchange on which registered
Dow Inc. Common Stock, par value $0.01 per share DOW New York Stock Exchange
The Dow Chemical Company 4.625% Notes due October 1, 2044 DOW/44 New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure

The press release of The Dow Chemical Company , announcing a full redemption of its 4.25% Notes due 2020 is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

The information included in this Current Report on Form 8-K under this Item 7.01 (including Exhibit 99.1) shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit No. Exhibit Description
99.1 Press Release of The Dow Chemical Company, dated May 20, 2019, announcing a full
redemption of the Company’s 4.25% Notes due 2020

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: May 20, 2019

Dow Inc. The Dow Chemical Company
By: /s/ Ronald C. Edmonds
Ronald C. Edmonds Controller and Vice President of Controllers and Tax